Global CDMO WORLDWIDE LEADER IN THE DEVELOPMENT AND Approved by top MANUFACTURING OF BLOW-FILL-SEAL (BFS) VIALS health authorities Introducing a new way to inject therapeutics This prototype device might be subject to changes. Proprietary information of Unither Pharmaceuticals. Open system, free of royalties Dedicated BSL2* building Competitive pricing Adaptable to any type of needle in our Amiens facility Opportunity for new Different routes of Very large capacity: markets (LMIC*) administration for injection up to 1 billion doses/year No risk of shortage in components and capacities *Biosafety level *Low middle income countries WHERE TO MEET US NEXT? CONTACT US LEARN MORE PharmaSynergy BIOASIA +33 (0) 1 44 63 51 70 8-9 feb. 2024 26-28 feb. 2024 contact@unither-pharma.com London, England Hyderabad, India www.unither-pharma.com